Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Completed 2Available 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2

Conditions

Osteosarcoma 2

Interventions

Cyclophosphamide 26Temozolomide 23Doxorubicin 22Radiotherapy 21Filgrastim 19Ifosfamide 15pazopanib 14Gemcitabine 14Etoposide 13Bevacizumab 13Irinotecan 12Cisplatin 12Magnetic Resonance Spectroscopy 11Imatinib Mesylate 11Granulocyte Colony-Stimulating Factor 11Carboplatin 11Radiation 9Methotrexate 9pembrolizumab 8fludarabine phosphate 8Rituximab 8Paclitaxel 8Docetaxel 8Cyclosporine 8Busulfan 8Antilymphocyte Serum 8fludarabine 7Vincristine 7Radiotherapy, Intensity-Modulated 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × mifamurtide × Sarcoma × Clear all
NCT02441309 2019-09-13

MEMOS

University of Oxford

Phase 2 Terminated
8 enrolled 17 charts
Sarcoma

Osteosarcoma

NCT01194284 2017-01-19

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Takeda

Terminated
25 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡